$12.05
11.9039[8147.78%]
Last update: 2:05PM Get Real Time Here
Pieris Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pieris Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/08/2024 | AM | PIRS | Q1 | -$0.18 | — | — | — | $1.94M | — | — | — | Get Alert |
05/07/2024 | AM | PIRS | Q4 | -$0.11 | -$0.12 | — | — | $5.85M | $1.30M | — | — | Get Alert |
11/14/2023 | PM | PIRS | Q3 | -$0.13 | -$0.11 | -$0.11 | 0.00% | $5.37M | $7.74M | $19.52M | 152.20% | Get Alert |
08/10/2023 | PM | PIRS | Q2 | -$0.14 | -$0.16 | $0.05 | 131.25% | $3.70M | $4.02M | $20.05M | 398.88% | Get Alert |
05/10/2023 | AM | PIRS | Q1 | -$0.07 | -$0.14 | -$0.18 | -28.57% | $10.99M | $6.50M | $1.94M | -70.22% | Get Alert |
03/29/2023 | AM | PIRS | Q4 | -$0.13 | -$0.23 | -$0.11 | 52.17% | $8.44M | $6.51M | $5.85M | -10.20% | Get Alert |
11/02/2022 | AM | PIRS | Q3 | -$0.24 | -$0.16 | -$0.13 | 18.75% | $4.06M | $2.26M | $5.37M | 137.61% | Get Alert |
08/04/2022 | AM | PIRS | Q2 | -$0.25 | -$0.11 | -$0.14 | -27.27% | $3.29M | $10.47M | $3.70M | -64.68% | Get Alert |
05/11/2022 | AM | PIRS | Q1 | -$0.07 | -$0.11 | -$0.07 | 36.36% | $15.63M | $11.30M | $10.99M | -2.76% | Get Alert |
03/01/2022 | AM | PIRS | Q4 | -$0.26 | -$0.30 | -$0.13 | 56.67% | $1.88M | $2.45M | $8.44M | 244.61% | Get Alert |
11/02/2021 | AM | PIRS | Q3 | -$0.26 | -$0.24 | -$0.24 | 0.00% | $2.94M | $5.32M | $4.06M | -23.74% | Get Alert |
08/04/2021 | AM | PIRS | Q2 | -$0.09 | -$0.26 | -$0.25 | 3.85% | $11.25M | $2.07M | $3.29M | 58.70% | Get Alert |
05/17/2021 | AM | PIRS | Q1 | -$0.07 | -$0.17 | -$0.07 | 58.82% | $13.26M | $6.47M | $15.63M | 141.62% | Get Alert |
03/30/2021 | AM | PIRS | Q4 | -$0.06 | -$0.24 | -$0.26 | -8.33% | $17.27M | $3.82M | $1.88M | -50.86% | Get Alert |
11/04/2020 | AM | PIRS | Q3 | -$0.05 | -$0.13 | -$0.26 | -100.00% | $15.13M | $9.79M | $2.94M | -69.98% | Get Alert |
08/10/2020 | AM | PIRS | Q2 | -$0.24 | -$0.17 | -$0.09 | 47.06% | $5.33M | $7.76M | $11.25M | 44.92% | Get Alert |
05/11/2020 | AM | PIRS | Q1 | -$0.20 | -$0.17 | -$0.07 | 58.82% | $8.54M | $8.84M | $13.26M | 50.01% | Get Alert |
03/12/2020 | AM | PIRS | Q4 | -$0.21 | -$0.28 | -$0.06 | 78.57% | $4.91M | $4.82M | $17.27M | 258.30% | Get Alert |
11/11/2019 | AM | PIRS | Q3 | -$0.11 | -$0.23 | -$0.05 | 78.26% | $8.35M | $6.42M | $15.13M | 135.70% | Get Alert |
Pieris Pharmaceuticals (PIRS) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
The Actual EPS was $-0.11, which hit the estimate of $-0.11.
The Actual Revenue was $19.5M, which beat the estimate of $7.7M.
Browse earnings estimates, EPS, and revenue on all stocks.